<?xml version="1.0" encoding="UTF-8"?>
<p id="Par106">Retrospective studies demonstrate positive outcomes with ribavirin (alone or in combination with immunomodulators) for the treatment of RSV infections in patients with hematological disease and HSCT. However, no prospective clinical studies have yet been conducted to demonstrate its clear efficacy [
 <xref ref-type="bibr" rid="CR5">5</xref>].
</p>
